A detailed history of Larson Financial Group LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Larson Financial Group LLC holds 220 shares of DVAX stock, worth $2,433. This represents 0.0% of its overall portfolio holdings.

Number of Shares
220
Previous 61 260.66%
Holding current value
$2,433
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$9.36 - $11.36 $1,488 - $1,806
159 Added 260.66%
220 $2,000
Q2 2025

Aug 08, 2025

BUY
$9.4 - $12.87 $488 - $669
52 Added 577.78%
61 $0
Q2 2024

Aug 02, 2024

BUY
$10.73 - $12.58 $96 - $113
9 New
9 $0

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.4B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.